trapidil has been researched along with Myocardial Ischemia in 5 studies
Trapidil: A coronary vasodilator agent.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adenosine and related compounds have been shown to produce atrioventricular (AV) conduction block during acute myocardial ischemia." | 7.78 | Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia. ( Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I, 2012) |
| "Adenosine and related compounds have been shown to produce atrioventricular (AV) conduction block during acute myocardial ischemia." | 3.78 | Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia. ( Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I, 2012) |
| "Aspirin was given to all patients, and ticlopidine 250 mg b." | 2.71 | Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. ( Balducelli, M; Barlera, S; Bernardi, G; Latini, R; Maggioni, AP; Maresta, A; Moccetti, T; Monici Preti, A; Ribeiro da Silva, EE; Sosa, C; Varani, E, 2005) |
| "Trapidil has shown a more complete antithrombocytic activity than other antiaggregating drugs; as a matter of fact it inhibits the formation of TXA2 through a mechanism of receptorial antagonism and at the same time it favours an increase of prostacyclina from the arterial walls." | 2.38 | [Trapidil after one year]. ( Agus, GB, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, I | 1 |
| Okumura, Y | 1 |
| Nagashima, K | 1 |
| Kofune, M | 1 |
| Ohkubo, K | 1 |
| Mano, H | 1 |
| Sonoda, K | 1 |
| Kasamaki, Y | 1 |
| Hirayama, A | 1 |
| Maresta, A | 1 |
| Balducelli, M | 1 |
| Latini, R | 1 |
| Bernardi, G | 1 |
| Moccetti, T | 1 |
| Sosa, C | 1 |
| Barlera, S | 1 |
| Varani, E | 1 |
| Ribeiro da Silva, EE | 1 |
| Monici Preti, A | 1 |
| Maggioni, AP | 1 |
| Agus, GB | 1 |
| Kotake, H | 1 |
| Sawada, Y | 1 |
| Hoshio, A | 1 |
| Shirota, K | 1 |
| Nawada, T | 1 |
| Yoshida, A | 1 |
| Hisatome, I | 1 |
| Miyakoda, H | 1 |
| Mashiba, H | 1 |
| Satoh, T | 1 |
| Otsuka, K | 1 |
| Sakurai, I | 1 |
1 review available for trapidil and Myocardial Ischemia
| Article | Year |
|---|---|
[Trapidil after one year].
Topics: Anticoagulants; Arm; Arteriosclerosis; Brain Ischemia; Clinical Trials as Topic; Drug Evaluation; Hu | 1993 |
1 trial available for trapidil and Myocardial Ischemia
| Article | Year |
|---|---|
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; | 2005 |
3 other studies available for trapidil and Myocardial Ischemia
| Article | Year |
|---|---|
Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia.
Topics: Adenosine; Angina Pectoris; Animals; Atrioventricular Block; Atrioventricular Node; Bundle of His; D | 2012 |
Effect of trapidil on serum lipid and apolipoprotein levels in patients with ischemic heart disease.
Topics: Aged; Apolipoproteins; Cholesterol, HDL; Female; Humans; Lipids; Male; Middle Aged; Myocardial Ische | 1993 |
[Method of quantitative measurement of human platelet aggregation in clinical practice].
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Dipyridamole; Epinephrine; Female; Humans; Male; Method | 1998 |